Home Medicine Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)
Article
Licensed
Unlicensed Requires Authentication

Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)

  • Edward O. Reiter , Nelly Mauras , Ken McCormick , Bindu Kulshreshtha , James Amrhein , Francesco De Luca , Sandra O'Brien , Jon Armstrong and Helena Melezinkova
Published/Copyright: October 1, 2010
Journal of Pediatric Endocrinology and Metabolism
From the journal Volume 23 Issue 10

ABSTRACT

Objective: To evaluate the efficacy, tolerability, and pharmacokinetics of bicalutamide plus anastrozole in young males with testotoxicosis.

Methods: This was a multicenter, open-label, single-arm, 12-month, Phase II pilot trial in 14 males (2-9 years) with testotoxicosis treated with bicalutamide (12.5, 25, 50, or 100 mg) and anastrozole (0.5 or 1 mg) daily. The primary outcome was change in growth rate.

Results: At 1 year, the mean (standard deviation) change from baseline in growth rate was -1.6 (± 5.1) cm/year and -0.1 (± 1.8) SD units, and in bone maturation was -2.3 (± 0.5) years. The bone age/chronological age ratio was reduced from 2.1 (± 0.6) at baseline to 1.0 (± 0.4) (p = 0.00013). Steady-state trough R-bicalutamide and anastrozole concentrations were attained by Day 21 and 8, respectively. Gynecomastia (42.9%) and breast tenderness (12.5%) were the most common treatment-related adverse events.

Conclusions: Treatment of testotoxicosis with bicalutamide plus anastrozole resulted in slower growth rate.


Corresponding author: Dr Edward Reiter,

Published Online: 2010-October
Published in Print: 2010-October

© Freund Publishing House Ltd.

Articles in the same Issue

  1. A Warning Sign from the Thyroid
  2. Variable Associations of Klinefelter Syndrome in Children
  3. Diabetes Insipidus in a Young Child
  4. Evaluation and Follow-up of Clinically Euthyroid Children with Normal Free T4 and Suppressed TSH
  5. Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)
  6. Endocannabinoid (EC) Receptor, CB1, and EC Enzymes' Expression in Primary Adipocyte Cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin
  7. The Relationship of Insulin Secretion and GAD65 Antibody Levels at Diagnosis on Glycemic Control in Type 2 Diabetes
  8. Morning Cortisol is Not Associated with Truncal Fatness or Resting Blood Pressure in Children: Cross-Sectional and 1-2 Year Follow-Up Analyses
  9. Decreased Plasma Apelin Levels in Pubertal Obese Children
  10. Adolescent Acromegaly: Clinical Parameters and Treatment Outcome
  11. Left Ventricular Diastolic Dysfunction in Adolescents with Type 1 Diabetes Reflects the Long- but Not Short- Term Metabolic Control
  12. Effects of a Structured Exercise Program on Insulin Resistance, Inflammatory Markers and Physical Fitness in Obese Korean Children
  13. Case Series of Neonatal Hypocalcemia due to Pseudohypoparathyroidism
  14. A Case of Antenatal Bartter Syndrome with Sensorineural Deafness
  15. Association of SUMO4 M55V Polymorphism with Type 1 Diabetes in Chinese Children
  16. Mayer-Rokintansky-Kuster-Hauser Syndrome Associated with Atrial Septal Defect, Partial Anomalous Pulmonary Venous Connection and Unilateral Kidney – An Unusual Triad of Anomalies
Downloaded on 12.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem.2010.161/html
Scroll to top button